Management of Spontaneous Intracerebral Hemorrhage

Research output: Contribution to journalReview article


Spontaneous intracerebral hemorrhage (ICH) has the highest mortality of all cerebrovascular events. Thirty-day mortality approaches 50%, and only 20% of survivors achieve meaningful functional recovery at 6 months. Many clinicians believe that effective therapies are lacking; however, this is changing because of new data on the pathophysiology and treatment of ICH, particularly research establishing the role of medical therapies to promote hematoma stabilization. This article provides updates to a recent publication discussing basic principles of ICH management, including initial stabilization, the prevention of hematoma growth, treatment of complications, and identification of the underlying etiology. Minimally invasive surgery (MIS) to reduce clot size is also discussed, with the goal of preserving neurologic function through reduction in parenchymal damage from edema formation.

Original languageEnglish (US)
Pages (from-to)373-384
Number of pages12
JournalNeurologic clinics
Issue number2
StatePublished - May 1 2008

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Management of Spontaneous Intracerebral Hemorrhage'. Together they form a unique fingerprint.

  • Cite this